Jingjing Shang

机构：Changzhou No.2 People's Hospital · ORCID：0000-0002-5267-933X

发表论文 100 篇 · 总被引 911 次 · h-index 17

代表论文

• Interobserver consistency and diagnostic challenges in HER2-ultralow breast cancer: a multicenter study (2025 · ESMO Open · 被引 26)
• Hyaluronic acid-based hydrogel microspheres with multi-responsive properties for antibacterial therapy and bone regeneration in Staphylococcus aureus-infected skull defects (2025 · Materials Today Bio · 被引 16)
• Cost-effectiveness of PD-1 inhibitors combined with chemotherapy for first-line treatment of oesophageal squamous cell carcinoma in China: a comprehensive analysis (2025 · Annals of Medicine · 被引 12)
• Low molecular weight heparin dosing regimens after total joint arthroplasty: a prospective, single-center, randomized, double-blind study (2024 · Journal of Orthopaedic Surgery and Research · 被引 10)
• Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis (2024 · PLoS ONE · 被引 10)
• Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe (2024 · International Journal of Clinical Pharmacy · 被引 8)